{"gene":"GABPA","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":1993,"finding":"GABPA (E4TF1-60) contains an ETS domain responsible for DNA binding, while its partner subunits (E4TF1-53 and E4TF1-47) contain tandem ankyrin/notch repeat motifs with no DNA-binding activity but capable of associating with GABPA; heterodimerization of these subunits is essential for transcription factor function, as demonstrated by cDNA cloning, recombinant expression in E. coli, and gel retardation assays.","method":"cDNA cloning, recombinant protein expression, gel retardation (EMSA) assay, antibody recognition","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution and DNA-binding assays with recombinant proteins, replicated with antibody validation","pmids":["8441384"],"is_preprint":false},{"year":1995,"finding":"Human nuclear respiratory factor 2 (NRF-2) is identical to GABP, composed of an alpha subunit (ETS domain DNA-binding) and four beta/gamma subunits (non-DNA-binding) sharing a conserved ~70 amino acid transcriptional activation domain containing repeated glutamine-containing hydrophobic clusters; all four beta/gamma subunits equally activate transcription when fused to a GAL4 DNA-binding domain, and the beta/gamma subunits are required to direct high-affinity alpha binding to tandem recognition sites.","method":"cDNA cloning, overexpression, transcription activation assay (GAL4 fusion), DNA-binding assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including functional transcription assays and DNA-binding reconstitution","pmids":["7799916"],"is_preprint":false},{"year":1998,"finding":"Crystal structure of the GABPα/β ETS domain–ankyrin repeat heterodimer bound to DNA at 2.15 Å resolution revealed that the ETS domain of GABPα binds its core GGA DNA-recognition motif, that GABPα recruits GABPβ using both the ETS domain and a C-terminal extension, and that an extensive protein–protein interface is formed by the ankyrin repeats of GABPβ.","method":"X-ray crystallography (2.15 Å resolution), ternary complex structure","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional domain validation","pmids":["9461436"],"is_preprint":false},{"year":2004,"finding":"GABP (via GABPα) binds the GGAA motif in the IL-7Rα promoter and is essential for IL-7Rα expression in T cells (but not B cells where PU.1 acts instead); mouse embryos with diminished GABPα expression showed substantially reduced IL-7Rα expression on thymocytes but normal expression on B220+ fetal liver B cells, demonstrating lineage-specific transcriptional regulation.","method":"ChIP, electrophoretic mobility shift assay, GABPα hypomorphic mouse model, flow cytometry","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal ChIP and in vivo genetic model with specific phenotypic readout","pmids":["15361867"],"is_preprint":false},{"year":2013,"finding":"GABP binds the YAP (Yes-associated protein) promoter and activates YAP transcription; GABP depletion downregulates YAP causing G1/S cell-cycle block and increased cell death rescued by YAP reconstitution. GABP transcriptional activity is inhibited by oxidative stress (acetaminophen-induced glutathione depletion), and Hippo signaling inhibits GABP activity through multiple mechanisms. In human liver cancers, elevated nuclear GABP correlates with enhanced YAP expression.","method":"ChIP, siRNA knockdown, cell cycle analysis, rescue experiments with YAP overexpression, acetaminophen liver injury model, IHC","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus epistasis rescue experiments, in vivo model, multiple orthogonal methods","pmids":["23684612"],"is_preprint":false},{"year":2014,"finding":"METTL23 (a methyltransferase-like protein) physically interacts with GABPα in both nucleus and cytoplasm; overexpression of METTL23 increases transcriptional activity at the THPO promoter, while siRNA knockdown of METTL23 decreases expression of ATP5B (a known GABP target gene), establishing METTL23 as a transcriptional partner that modulates GABP activity.","method":"Co-immunoprecipitation, overexpression, siRNA knockdown, luciferase promoter assay, subcellular localization","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2/3 — Co-IP with functional transcription assay, single lab study","pmids":["24501276"],"is_preprint":false},{"year":2015,"finding":"GABP (as a multimeric complex) is the sole ETS transcription factor that selectively binds the mutant TERT promoter (harboring -124C>T or -146C>T mutations creating a de novo ETS motif) in glioblastoma and other cancer types; allelic GABP recruitment is observed across four cancer types and tandem flanking native ETS motifs cooperate with the mutation to activate TERT, likely by facilitating GABP heterotetramer binding.","method":"ChIP-seq, EMSA, luciferase reporter assay, allele-specific binding analysis across multiple cancer cell lines","journal":"Science","confidence":"High","confidence_rationale":"Tier 1/2 — multiple orthogonal methods, replicated across four cancer types, mechanistically defined","pmids":["25977370"],"is_preprint":false},{"year":2015,"finding":"CAPER coactivates the nuclear receptor ERR-α to drive GABPA transcription in response to glucose/nutrient signaling, thereby linking nutrient-induced mitochondrial energy metabolism to GABP-dependent transcriptional programs; inhibition of CAPER arrests nutrient-dependent ATP generation and suppresses GABPA expression.","method":"siRNA knockdown, gene expression analysis, metabolic assays (ATP measurement, oxygen consumption), ChIP","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2/3 — multiple functional assays but indirect evidence for GABPA as downstream target of ERR-α/CAPER","pmids":["25830341"],"is_preprint":false},{"year":2016,"finding":"GABPA recruitment to mutant TERT promoters mediates long-range chromatin interactions and enrichment of active histone marks (H3K4me3, H3K27ac) to drive TERT transcription; CRISPR-mediated reversion of mutant TERT promoters abrogated GABPA binding and long-range interactions, eliminated active histone marks, and suppressed TERT transcription, while de novo introduction of a TERT promoter mutation enabled GABPA binding and TERT upregulation.","method":"Chromatin conformation capture (3C/ChIA-PET), CRISPR/Cas9 editing, ChIP-seq, luciferase reporter assay","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 1/2 — CRISPR-based gain and loss of function with multiple chromatin-based readouts, mechanistically rigorous","pmids":["27650951"],"is_preprint":false},{"year":2018,"finding":"GABPA directly activates DICER1 transcription by binding its promoter; GABPA depletion reduced DICER1 expression and robustly increased cellular invasion in thyroid carcinoma cells independently of TERT promoter mutations. Forced DICER1 expression rescued the invasiveness of GABPA-depleted cells, establishing DICER1 as a downstream effector of GABPA in suppressing invasion/metastasis.","method":"siRNA/shRNA knockdown, luciferase promoter assay with GABPA-binding site mutation, rescue overexpression, invasion assay, patient cohort correlation analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — promoter mutagenesis, epistasis rescue experiment, and in vivo patient data; multiple orthogonal methods","pmids":["30181547"],"is_preprint":false},{"year":2019,"finding":"GABPA directly activates transcription of FOXA1 and GATA3, key transcription factors driving luminal differentiation of urothelial cells in bladder cancer; GABPA ablation inhibited TERT expression but increased proliferation, stem/invasive phenotypes, and cisplatin resistance, while overexpression exhibited opposite effects and inhibited in vivo metastasis in a xenograft model, establishing GABPA as a master regulator of luminal identity.","method":"ChIP, shRNA/CRISPR knockout, overexpression, xenograft mouse model, invasion/stemness assays, TCGA dataset analysis","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — ChIP for direct target validation, in vivo xenograft, multiple phenotypic readouts, replicated in patient datasets","pmids":["31802036"],"is_preprint":false}],"current_model":"GABPA is an ETS-family transcription factor that forms obligate heterodimers/heterotetramers with GABPB subunits (which provide ankyrin-repeat-mediated protein–protein interaction and a conserved transcriptional activation domain) to bind GGA-containing promoter elements and activate target genes including IL-7Rα, YAP, DICER1, FOXA1, GATA3, and ATP5B; uniquely among ETS factors, GABP heterotetramers are selectively recruited to cancer-specific mutant TERT promoters (−124C>T/−146C>T), where they drive long-range chromatin interactions and active histone mark deposition to reactivate TERT transcription, while in normal developmental contexts GABPA functions as a tumor suppressor by maintaining luminal differentiation and suppressing invasion."},"narrative":{"teleology":[{"year":1993,"claim":"Establishing that GABP is a heteromeric transcription factor resolved how the DNA-binding (ETS domain in GABPA) and transcriptional activation functions are partitioned between distinct subunits.","evidence":"cDNA cloning of E4TF1 subunits, recombinant expression in E. coli, and gel retardation assays","pmids":["8441384"],"confidence":"High","gaps":["No structural detail of the heterodimer interface","Activation domain not yet mapped"]},{"year":1995,"claim":"Identification of NRF-2 as identical to GABP and mapping of a conserved ~70 amino acid activation domain in all four beta/gamma subunits established the molecular basis for GABP-dependent transcriptional activation.","evidence":"GAL4-fusion transcription assays and DNA-binding reconstitution with recombinant subunits","pmids":["7799916"],"confidence":"High","gaps":["Structural basis for how beta subunits enhance DNA-binding affinity at tandem sites unknown","In vivo target gene repertoire undefined"]},{"year":1998,"claim":"The crystal structure of the GABPA/GABPB ETS–ankyrin repeat complex on DNA defined the atomic-level protein–protein and protein–DNA interfaces, explaining how GABPB is recruited exclusively through GABPA contacts.","evidence":"X-ray crystallography at 2.15 Å resolution of the ternary complex","pmids":["9461436"],"confidence":"High","gaps":["Heterotetramer assembly on tandem sites not structurally resolved","No structural insight into full-length subunits or activation domain"]},{"year":2004,"claim":"Demonstrating that GABPA is essential for IL-7Rα expression specifically in T cells but dispensable in B cells revealed lineage-specific transcriptional regulation by GABP in immune development.","evidence":"ChIP, EMSA, and GABPA hypomorphic mouse model with flow cytometric phenotyping","pmids":["15361867"],"confidence":"High","gaps":["Mechanism of T-cell versus B-cell specificity beyond PU.1 compensation unclear","Downstream consequences for thymocyte development not fully delineated"]},{"year":2013,"claim":"Discovery that GABP directly activates YAP transcription and that oxidative stress inhibits GABP activity connected GABP to Hippo pathway signaling and cell cycle control.","evidence":"ChIP, siRNA knockdown with YAP rescue, acetaminophen liver injury model, immunohistochemistry in human liver cancers","pmids":["23684612"],"confidence":"High","gaps":["Mechanism of oxidative stress-mediated GABP inhibition not defined at the molecular level","Whether GABP–YAP axis operates outside hepatocytes unknown"]},{"year":2015,"claim":"Identification of GABP as the sole ETS factor selectively recruited to mutant TERT promoters across multiple cancer types answered how recurrent TERT promoter mutations reactivate telomerase, revealing that de novo ETS motifs and flanking native ETS sites cooperate to recruit GABP heterotetramers.","evidence":"ChIP-seq, EMSA, luciferase reporters, allele-specific binding across four cancer cell lines","pmids":["25977370"],"confidence":"High","gaps":["Structural basis for heterotetramer selectivity at mutant versus wild-type TERT promoter unclear","Whether other cofactors contribute to allele-specific recruitment not addressed"]},{"year":2016,"claim":"CRISPR-based gain- and loss-of-function experiments demonstrated that GABPA binding at mutant TERT promoters is both necessary and sufficient to establish long-range chromatin interactions and active histone marks, providing a complete chromatin-level mechanism for mutation-driven TERT reactivation.","evidence":"CRISPR/Cas9 editing of TERT promoter mutations, 3C/ChIA-PET, ChIP-seq for H3K4me3 and H3K27ac","pmids":["27650951"],"confidence":"High","gaps":["Identity of distal regulatory elements contacted by GABP-mediated loops not fully characterized","Whether pharmacological disruption of GABP–TERT interaction is feasible not tested"]},{"year":2018,"claim":"Identification of DICER1 as a direct GABPA target whose loss mediates the pro-invasive phenotype of GABPA depletion established GABPA as a suppressor of invasion through miRNA biogenesis, independent of its role in TERT regulation.","evidence":"Promoter mutagenesis, siRNA/shRNA knockdown, DICER1 rescue of invasion phenotype in thyroid carcinoma cells","pmids":["30181547"],"confidence":"High","gaps":["Specific miRNAs downstream of DICER1 mediating invasion suppression not identified","Whether this axis operates in non-thyroid tissues not tested"]},{"year":2019,"claim":"Demonstrating that GABPA directly activates FOXA1 and GATA3 to drive luminal differentiation in urothelial cells established GABPA as a master regulator of epithelial cell identity, explaining the paradox that GABPA loss can promote proliferation and invasion even while reducing TERT expression.","evidence":"ChIP, CRISPR knockout, xenograft metastasis model, TCGA dataset analysis","pmids":["31802036"],"confidence":"High","gaps":["Upstream signals controlling GABPA expression in urothelium not defined","Whether GABPA drives luminal programs in other epithelial tissues not established"]},{"year":null,"claim":"Major unresolved questions include the structural basis for GABP heterotetramer selectivity at mutant versus wild-type TERT promoters, the complete downstream target repertoire in different lineages, and whether GABPA can be therapeutically targeted to selectively suppress mutant-TERT-driven cancers without disrupting its tumor-suppressive differentiation programs.","evidence":"","pmids":[],"confidence":"Low","gaps":["No heterotetramer structure on tandem ETS sites available","No systematic comparison of GABPA target genes across tissue types","No therapeutic strategy addressing the dual oncogene-tumor suppressor paradox"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,4,6,8,9,10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,5,6,8]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,3,4,6,8,9,10]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[8]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10]}],"complexes":["GABP heterodimer (GABPA/GABPB)","GABP heterotetramer"],"partners":["GABPB1","GABPB2","METTL23","TERT"],"other_free_text":[]},"mechanistic_narrative":"GABPA is an ETS-family transcription factor that heterodimerizes with GABPB subunits through its ETS domain and a C-terminal extension to form obligate heterodimers and heterotetramers that bind GGA-containing promoter elements and activate transcription of diverse target genes including IL-7Rα, YAP, DICER1, FOXA1, and GATA3 [PMID:8441384, PMID:9461436, PMID:15361867, PMID:30181547, PMID:31802036]. The GABPB subunits contribute ankyrin-repeat-mediated protein–protein interaction surfaces and a conserved glutamine-rich transcriptional activation domain, while GABPA provides all DNA-contact specificity [PMID:8441384, PMID:7799916, PMID:9461436]. Uniquely among ETS factors, GABP heterotetramers are selectively recruited to cancer-associated mutant TERT promoters (−124C>T/−146C>T), where they establish long-range chromatin interactions and active histone marks to reactivate TERT transcription [PMID:25977370, PMID:27650951]. In normal epithelial and immune contexts, GABPA functions as a lineage-specific transcriptional regulator—driving T-cell IL-7Rα expression, luminal differentiation in urothelium via FOXA1/GATA3, and suppression of invasion through DICER1 activation [PMID:15361867, PMID:31802036, PMID:30181547]."},"prefetch_data":{"uniprot":{"accession":"Q06546","full_name":"GA-binding protein alpha chain","aliases":["Nuclear respiratory factor 2 subunit alpha","Transcription factor E4TF1-60"],"length_aa":454,"mass_kda":51.3,"function":"Transcription factor capable of interacting with purine rich repeats (GA repeats). Positively regulates transcription of transcriptional repressor RHIT/ZNF205 (PubMed:22306510) (Microbial infection) Necessary for the expression of the Adenovirus E4 gene","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q06546/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/GABPA","classification":"Common Essential","n_dependent_lines":1007,"n_total_lines":1208,"dependency_fraction":0.8336092715231788},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABPA","total_profiled":1310},"omim":[{"mim_id":"621284","title":"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, SUBUNIT BETA-2; GABPB2","url":"https://www.omim.org/entry/621284"},{"mim_id":"621279","title":"LONG INTERGENIC NON-PROTEIN CODING RNA 1011; LINC01011","url":"https://www.omim.org/entry/621279"},{"mim_id":"620758","title":"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23B; TIMM23B","url":"https://www.omim.org/entry/620758"},{"mim_id":"620738","title":"ZONE OF POLARIZING ACTIVITY REGULATORY SEQUENCE; ZRS","url":"https://www.omim.org/entry/620738"},{"mim_id":"615942","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 44; MRT44","url":"https://www.omim.org/entry/615942"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GABPA"},"hgnc":{"alias_symbol":["E4TF1A","NFT2","NRF2","E4TF1-60","NRF2A"],"prev_symbol":[]},"alphafold":{"accession":"Q06546","domains":[{"cath_id":"3.10.20.90","chopping":"35-113","consensus_level":"high","plddt":85.1076,"start":35,"end":113},{"cath_id":"1.10.150.50","chopping":"159-256","consensus_level":"medium","plddt":77.8062,"start":159,"end":256},{"cath_id":"1.10.10.10","chopping":"321-432","consensus_level":"medium","plddt":89.247,"start":321,"end":432}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q06546","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q06546-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q06546-F1-predicted_aligned_error_v6.png","plddt_mean":67.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABPA","jax_strain_url":"https://www.jax.org/strain/search?query=GABPA"},"sequence":{"accession":"Q06546","fasta_url":"https://rest.uniprot.org/uniprotkb/Q06546.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q06546/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q06546"}},"corpus_meta":[{"pmid":"28899199","id":"PMC_28899199","title":"Transcriptional Regulation by Nrf2.","date":"2017","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/28899199","citation_count":1694,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29731393","id":"PMC_29731393","title":"NRF2 and the Hallmarks of Cancer.","date":"2018","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/29731393","citation_count":1325,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21365312","id":"PMC_21365312","title":"The cytoprotective role of the Keap1-Nrf2 pathway.","date":"2011","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/21365312","citation_count":816,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25975984","id":"PMC_25975984","title":"The emerging role of Nrf2 in mitochondrial function.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25975984","citation_count":764,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23434765","id":"PMC_23434765","title":"Regulation of Nrf2-an update.","date":"2013","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23434765","citation_count":738,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18838122","id":"PMC_18838122","title":"Dual roles of Nrf2 in cancer.","date":"2008","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/18838122","citation_count":546,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26117325","id":"PMC_26117325","title":"p62 links autophagy and Nrf2 signaling.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26117325","citation_count":535,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27263465","id":"PMC_27263465","title":"The Dual Roles of NRF2 in Cancer.","date":"2016","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27263465","citation_count":519,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26057936","id":"PMC_26057936","title":"Structural basis of Keap1 interactions with Nrf2.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26057936","citation_count":465,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28523248","id":"PMC_28523248","title":"The KEAP1-NRF2 System in Cancer.","date":"2017","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28523248","citation_count":427,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36724221","id":"PMC_36724221","title":"NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36724221","citation_count":390,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34732330","id":"PMC_34732330","title":"Nrf2/Keap1/ARE signaling: Towards specific regulation.","date":"2021","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34732330","citation_count":387,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19538984","id":"PMC_19538984","title":"Nrf2 signaling and cell survival.","date":"2009","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19538984","citation_count":335,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28969555","id":"PMC_28969555","title":"Oxidative Stress and Cancer: The Role of Nrf2.","date":"2018","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/28969555","citation_count":325,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28066829","id":"PMC_28066829","title":"The multifaceted role of Nrf2 in mitochondrial function.","date":"2016","source":"Current opinion in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28066829","citation_count":308,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19490732","id":"PMC_19490732","title":"The Nrf2-ARE cytoprotective pathway in astrocytes.","date":"2009","source":"Expert reviews in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19490732","citation_count":247,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30728889","id":"PMC_30728889","title":"Role of Nrf2 and Its Activators in Respiratory Diseases.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/30728889","citation_count":228,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29242678","id":"PMC_29242678","title":"KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane.","date":"2017","source":"Trends in food science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/29242678","citation_count":218,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32234331","id":"PMC_32234331","title":"Beyond repression of Nrf2: An update on Keap1.","date":"2020","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32234331","citation_count":214,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26117320","id":"PMC_26117320","title":"Epigenetic regulation of Keap1-Nrf2 signaling.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26117320","citation_count":208,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29438305","id":"PMC_29438305","title":"The Crosstalk between Nrf2 and Inflammasomes.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29438305","citation_count":194,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37760042","id":"PMC_37760042","title":"NRF2, a Superstar of Ferroptosis.","date":"2023","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37760042","citation_count":193,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35359876","id":"PMC_35359876","title":"Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35359876","citation_count":176,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25278702","id":"PMC_25278702","title":"Role of Nrf2 in chronic liver disease.","date":"2014","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25278702","citation_count":173,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24741667","id":"PMC_24741667","title":"(-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways.","date":"2014","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24741667","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35223849","id":"PMC_35223849","title":"The Nrf2 Pathway in Liver Diseases.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35223849","citation_count":152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35101864","id":"PMC_35101864","title":"NRF2: KEAPing Tumors Protected.","date":"2022","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35101864","citation_count":150,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26555609","id":"PMC_26555609","title":"NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26555609","citation_count":149,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30760522","id":"PMC_30760522","title":"NRF2 Activation in Cancer: From DNA to Protein.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30760522","citation_count":148,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20486759","id":"PMC_20486759","title":"The Nrf2-Keap1-ARE signaling pathway: The regulation and dual function of Nrf2 in cancer.","date":"2010","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20486759","citation_count":146,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19530984","id":"PMC_19530984","title":"Targeting the Nrf2 pathway against cardiovascular disease.","date":"2009","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/19530984","citation_count":144,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31097977","id":"PMC_31097977","title":"Potential Applications of NRF2 Inhibitors in Cancer Therapy.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31097977","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30274149","id":"PMC_30274149","title":"Role of Hydrogen Sulfide in NRF2- and Sirtuin-Dependent Maintenance of Cellular Redox Balance.","date":"2018","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30274149","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31972171","id":"PMC_31972171","title":"Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification.","date":"2020","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31972171","citation_count":131,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31692987","id":"PMC_31692987","title":"Regulation of Nrf2 Signaling.","date":"2019","source":"Reactive oxygen species (Apex, N.C.)","url":"https://pubmed.ncbi.nlm.nih.gov/31692987","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32106613","id":"PMC_32106613","title":"Potential Applications of NRF2 Modulators in Cancer Therapy.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32106613","citation_count":125,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35268403","id":"PMC_35268403","title":"Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases.","date":"2022","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35268403","citation_count":123,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26511009","id":"PMC_26511009","title":"Role of Nrf2 in bone metabolism.","date":"2015","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/26511009","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31283051","id":"PMC_31283051","title":"Melatonin as a potential modulator of Nrf2.","date":"2019","source":"Fundamental & clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31283051","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28411557","id":"PMC_28411557","title":"Controversy about pharmacological modulation of Nrf2 for cancer therapy.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28411557","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24892215","id":"PMC_24892215","title":"The PTEN/NRF2 axis promotes human carcinogenesis.","date":"2014","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/24892215","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35453348","id":"PMC_35453348","title":"Role of NRF2 in Ovarian Cancer.","date":"2022","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35453348","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34443584","id":"PMC_34443584","title":"The Nrf2 Pathway in Ischemic Stroke: A Review.","date":"2021","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34443584","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37296665","id":"PMC_37296665","title":"Modulation of NRF2/KEAP1 Signaling in Preeclampsia.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/37296665","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26970133","id":"PMC_26970133","title":"Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane.","date":"2015","source":"Seminars in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26970133","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26003520","id":"PMC_26003520","title":"Crosstalk between Nrf2 and Notch signaling.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26003520","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26117322","id":"PMC_26117322","title":"Mechanisms and functions of Nrf2 signaling in Drosophila.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26117322","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34440648","id":"PMC_34440648","title":"Role of NRF2 in Lung Cancer.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34440648","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37531930","id":"PMC_37531930","title":"EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37531930","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28453520","id":"PMC_28453520","title":"WDR23 regulates NRF2 independently of KEAP1.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28453520","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34020028","id":"PMC_34020028","title":"The intricacies of NRF2 regulation in cancer.","date":"2021","source":"Seminars in cancer biology","url":"https://pubmed.ncbi.nlm.nih.gov/34020028","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19573594","id":"PMC_19573594","title":"Nrf2 promotes neuronal cell differentiation.","date":"2009","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19573594","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27109910","id":"PMC_27109910","title":"Exercise-induced Nrf2-signaling is impaired in aging.","date":"2016","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27109910","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32784785","id":"PMC_32784785","title":"Current Landscape of NRF2 Biomarkers in Clinical Trials.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32784785","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28473877","id":"PMC_28473877","title":"Involvement of Nrf2 in Ocular Diseases.","date":"2017","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/28473877","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32918185","id":"PMC_32918185","title":"Role of Nrf2 in cell senescence regulation.","date":"2020","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32918185","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36930785","id":"PMC_36930785","title":"The KEAP1-NRF2 System and Neurodegenerative Diseases.","date":"2023","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/36930785","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32938017","id":"PMC_32938017","title":"Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32938017","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30759236","id":"PMC_30759236","title":"Targeting IDH1-Mutated Malignancies with NRF2 Blockade.","date":"2019","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/30759236","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24630992","id":"PMC_24630992","title":"Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24630992","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28692050","id":"PMC_28692050","title":"Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28692050","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35645796","id":"PMC_35645796","title":"Role of Phytochemicals in Skin Photoprotection via Regulation of Nrf2.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35645796","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36289931","id":"PMC_36289931","title":"Nrf2 Modulation in Breast Cancer.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/36289931","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26117318","id":"PMC_26117318","title":"Functional polymorphisms in Nrf2: implications for human disease.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26117318","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30528955","id":"PMC_30528955","title":"Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-κBp65 pathway.","date":"2018","source":"Pulmonary pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/30528955","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38247494","id":"PMC_38247494","title":"The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?","date":"2024","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38247494","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32620467","id":"PMC_32620467","title":"Role of Nrf2 in rheumatoid arthritis.","date":"2020","source":"Current research in translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32620467","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33069760","id":"PMC_33069760","title":"Flavonoids targeting NRF2 in neurodegenerative disorders.","date":"2020","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/33069760","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36174411","id":"PMC_36174411","title":"Regulation of innate immunity by Nrf2.","date":"2022","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36174411","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30271424","id":"PMC_30271424","title":"Molecular Pathways Associated With Methylmercury-Induced Nrf2 Modulation.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30271424","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32057361","id":"PMC_32057361","title":"The acetyltransferase p300 regulates NRF2 stability and localization.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32057361","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26325326","id":"PMC_26325326","title":"Regulation of Ahr signaling by Nrf2 during development: Effects of Nrf2a deficiency on PCB126 embryotoxicity in zebrafish (Danio rerio).","date":"2015","source":"Aquatic toxicology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/26325326","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30181547","id":"PMC_30181547","title":"GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30181547","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39456522","id":"PMC_39456522","title":"Modulation of NRF2/KEAP1 Signaling by Phytotherapeutics in Periodontitis.","date":"2024","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/39456522","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17440634","id":"PMC_17440634","title":"Chemopreventive promise of targeting the Nrf2 pathway.","date":"2007","source":"Drug news & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/17440634","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32893883","id":"PMC_32893883","title":"Functional, proteomic and bioinformatic analyses of Nrf2- and Keap1- null skeletal muscle.","date":"2020","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32893883","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26345522","id":"PMC_26345522","title":"miRNA Influences in NRF2 Pathway Interactions within Cancer Models.","date":"2015","source":"Journal of nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/26345522","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29082352","id":"PMC_29082352","title":"NRF2-targeted therapeutics: New targets and modes of NRF2 regulation.","date":"2016","source":"Current opinion in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29082352","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31802036","id":"PMC_31802036","title":"GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/31802036","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34067331","id":"PMC_34067331","title":"Keap1/Nrf2 Signaling Pathway.","date":"2021","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34067331","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35204110","id":"PMC_35204110","title":"AHR and NRF2 in Skin Homeostasis and Atopic Dermatitis.","date":"2022","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35204110","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34455076","id":"PMC_34455076","title":"The pivotal role of Nrf2 activators in adipocyte biology.","date":"2021","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/34455076","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25830341","id":"PMC_25830341","title":"CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-α-Gabpa and stress-induced adaptive responses via NF-κB-cMYC.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25830341","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28601065","id":"PMC_28601065","title":"Mazes of Nrf2 Regulation.","date":"2017","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/28601065","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24501276","id":"PMC_24501276","title":"METTL23, a transcriptional partner of GABPA, is essential for human cognition.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24501276","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32423098","id":"PMC_32423098","title":"Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications.","date":"2020","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/32423098","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25224039","id":"PMC_25224039","title":"Nuclear Nrf2 induction by protein transduction attenuates osteoclastogenesis.","date":"2014","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25224039","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36050469","id":"PMC_36050469","title":"NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36050469","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36979026","id":"PMC_36979026","title":"Activators of Nrf2 to Counteract Neurodegenerative Diseases.","date":"2023","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36979026","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30959808","id":"PMC_30959808","title":"Concomitant Nrf2- and ATF4-activation by Carnosic Acid Cooperatively Induces Expression of Cytoprotective Genes.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30959808","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28978049","id":"PMC_28978049","title":"ROS-independent Nrf2 activation in prostate cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28978049","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38514704","id":"PMC_38514704","title":"GAS41 modulates ferroptosis by anchoring NRF2 on chromatin.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38514704","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34954079","id":"PMC_34954079","title":"Iron-mediated epigenetic activation of NRF2 targets.","date":"2021","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34954079","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38830868","id":"PMC_38830868","title":"PPIA dictates NRF2 stability to promote lung cancer progression.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38830868","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37619563","id":"PMC_37619563","title":"Succinylation of a KEAP1 sensor lysine promotes NRF2 activation.","date":"2023","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37619563","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32823937","id":"PMC_32823937","title":"The KEAP1/NRF2 Signaling Pathway in Keratinization.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32823937","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33912042","id":"PMC_33912042","title":"The Role of Nrf2 in Hearing Loss.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33912042","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31372933","id":"PMC_31372933","title":"Filtering through the role of NRF2 in kidney disease.","date":"2019","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/31372933","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36213179","id":"PMC_36213179","title":"An NRF2 Perspective on Stem Cells and Ageing.","date":"2021","source":"Frontiers in aging","url":"https://pubmed.ncbi.nlm.nih.gov/36213179","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31489470","id":"PMC_31489470","title":"Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy.","date":"2019","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31489470","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19274049","id":"PMC_19274049","title":"A census of human transcription factors: function, expression and evolution.","date":"2009","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19274049","citation_count":1191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28473536","id":"PMC_28473536","title":"Impact of cytosine methylation on DNA binding specificities of human transcription factors.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28473536","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10830953","id":"PMC_10830953","title":"The DNA sequence of human chromosome 21.","date":"2000","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10830953","citation_count":808,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25977370","id":"PMC_25977370","title":"Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.","date":"2015","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25977370","citation_count":452,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9461436","id":"PMC_9461436","title":"The structure of GABPalpha/beta: an ETS domain- ankyrin repeat heterodimer bound to DNA.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9461436","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30415952","id":"PMC_30415952","title":"MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30415952","citation_count":152,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21832049","id":"PMC_21832049","title":"Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832049","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27650951","id":"PMC_27650951","title":"Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.","date":"2016","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/27650951","citation_count":128,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35140242","id":"PMC_35140242","title":"Human transcription factor protein interaction networks.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35140242","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25609649","id":"PMC_25609649","title":"Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.","date":"2015","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/25609649","citation_count":120,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19687146","id":"PMC_19687146","title":"Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery.","date":"2009","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/19687146","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15361867","id":"PMC_15361867","title":"GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells.","date":"2004","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15361867","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23684612","id":"PMC_23684612","title":"The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23684612","citation_count":112,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7799916","id":"PMC_7799916","title":"Four structurally distinct, non-DNA-binding subunits of human nuclear respiratory factor 2 share a conserved transcriptional activation domain.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7799916","citation_count":100,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8441384","id":"PMC_8441384","title":"cDNA cloning of transcription factor E4TF1 subunits with Ets and notch motifs.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8441384","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12107413","id":"PMC_12107413","title":"Expressed sequence tag analysis of adult human lens for the NEIBank Project: over 2000 non-redundant transcripts, novel genes and splice variants.","date":"2002","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/12107413","citation_count":86,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44182,"output_tokens":998,"usd":0.073758},"stage2":{"model":"claude-opus-4-6","input_tokens":4219,"output_tokens":1666,"usd":0.094118},"total_usd":0.419704,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":56085,"output_tokens":3341,"usd":0.109185},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6524,"output_tokens":2499,"usd":0.142643}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"GABPA directly activates transcription of FoxA1 and GATA3, key transcription factors driving luminal differentiation of urothelial cells, thereby maintaining luminal identity and suppressing aggressive phenotypes in bladder cancer cells.\",\n      \"method\": \"GABPA depletion/overexpression with phenotypic readouts (proliferation, invasion, stemness, cisplatin resistance), in vivo xenograft metastasis model, TCGA/GEO dataset correlation analyses\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO/OE with defined cellular phenotypes plus in vivo model and mechanistic pathway placement via direct transcriptional targets\",\n      \"pmids\": [\"31802036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GABPA inhibits invasion and metastasis in papillary thyroid carcinoma by directly activating DICER1 transcription; mutation of the GABPA binding site in the DICER1 promoter abolishes both basal and GABPA-stimulated promoter activity, and forced DICER1 re-expression rescues the invasiveness caused by GABPA depletion.\",\n      \"method\": \"siRNA knockdown, promoter reporter assays with GABPA-binding-site mutagenesis, rescue experiments with forced DICER1 expression, patient tissue correlation analyses\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — promoter mutagenesis plus functional rescue, multiple orthogonal methods in one study\",\n      \"pmids\": [\"30181547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"METTL23 physically interacts with GABPA and acts as a transcriptional co-regulator of GABPA function; overexpression of METTL23 increases transcriptional activity at the THPO promoter, and knockdown of METTL23 decreases expression of ATP5B, a known GABPA target gene.\",\n      \"method\": \"Co-immunoprecipitation (physical interaction), overexpression and siRNA knockdown with promoter activity and target gene expression readouts, subcellular localization imaging\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal interaction data plus functional gene expression readouts, single study\",\n      \"pmids\": [\"24501276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CAPER coactivates nuclear receptor ERR-α to drive GABPA transcription, linking nutrient (glucose) signaling to mitochondrial energy metabolism; inhibition of CAPER arrests nutrient-dependent ATP generation and cell proliferation.\",\n      \"method\": \"CAPER inhibition/knockdown with measurements of ATP generation, cell proliferation, and GABPA transcriptional output; coactivation assays with ERR-α\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional coactivation assay with metabolic readouts, single study with multiple endpoints\",\n      \"pmids\": [\"25830341\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABPA is an ETS-family transcription factor that directly binds and activates target gene promoters (including DICER1, FoxA1, GATA3, TERT mutant promoter, and ATP5B/THPO via its partner GABPB1 and co-regulator METTL23), thereby controlling cellular differentiation, invasion suppression, and mitochondrial gene expression programs; its transcriptional activity is itself regulated upstream by the CAPER–ERR-α axis in response to nutrient signals.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nLooking through the corpus, I need to identify papers about the canonical GABPA protein (GA-binding protein alpha, an ETS family transcription factor).\n\n**Classification:**\n- Papers [1]-[72], [74]-[82], [84]-[100] in the main corpus are about NRF2/KEAP1 signaling — these are EXCLUDE (alias collision: \"NRF2\" papers, not GABPA).\n- Paper [73] (PMID:30181547): GABPA in thyroid carcinoma — KEEP\n- Paper [79] (PMID:31802036): GABPA in bladder cancer — KEEP\n- Paper [83] (PMID:25830341): CAPER/ERR-α/Gabpa in mitochondrial energy metabolism — KEEP\n- Paper [85] (PMID:24501276): METTL23 interacts with GABPA — KEEP\n\n**Additional curated papers:**\n- [12] (PMID:25977370): GABP binds mutant TERT promoter — KEEP\n- [17] (PMID:9461436): Crystal structure of GABPα/β — KEEP\n- [21] (PMID:27650951): GABPA/mutant TERT promoter via long-range chromatin interactions — KEEP\n- [26] (PMID:15361867): GABP regulates IL-7Rα in T cells — KEEP\n- [27] (PMID:23684612): GABP activates YAP transcription — KEEP\n- [28] (PMID:7799916): NRF-2/GABP subunits characterization — KEEP\n- [29] (PMID:8441384): E4TF1/GABP subunit cloning — KEEP\n- Others are genome/proteome-wide studies that incidentally list GABPA — I'll include those that provide specific mechanistic findings about GABPA interactions.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GABPA (E4TF1-60) contains an ETS domain responsible for DNA binding, while its partner subunits (E4TF1-53 and E4TF1-47) contain tandem ankyrin/notch repeat motifs with no DNA-binding activity but capable of associating with GABPA; heterodimerization of these subunits is essential for transcription factor function, as demonstrated by cDNA cloning, recombinant expression in E. coli, and gel retardation assays.\",\n      \"method\": \"cDNA cloning, recombinant protein expression, gel retardation (EMSA) assay, antibody recognition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution and DNA-binding assays with recombinant proteins, replicated with antibody validation\",\n      \"pmids\": [\"8441384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Human nuclear respiratory factor 2 (NRF-2) is identical to GABP, composed of an alpha subunit (ETS domain DNA-binding) and four beta/gamma subunits (non-DNA-binding) sharing a conserved ~70 amino acid transcriptional activation domain containing repeated glutamine-containing hydrophobic clusters; all four beta/gamma subunits equally activate transcription when fused to a GAL4 DNA-binding domain, and the beta/gamma subunits are required to direct high-affinity alpha binding to tandem recognition sites.\",\n      \"method\": \"cDNA cloning, overexpression, transcription activation assay (GAL4 fusion), DNA-binding assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including functional transcription assays and DNA-binding reconstitution\",\n      \"pmids\": [\"7799916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Crystal structure of the GABPα/β ETS domain–ankyrin repeat heterodimer bound to DNA at 2.15 Å resolution revealed that the ETS domain of GABPα binds its core GGA DNA-recognition motif, that GABPα recruits GABPβ using both the ETS domain and a C-terminal extension, and that an extensive protein–protein interface is formed by the ankyrin repeats of GABPβ.\",\n      \"method\": \"X-ray crystallography (2.15 Å resolution), ternary complex structure\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional domain validation\",\n      \"pmids\": [\"9461436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GABP (via GABPα) binds the GGAA motif in the IL-7Rα promoter and is essential for IL-7Rα expression in T cells (but not B cells where PU.1 acts instead); mouse embryos with diminished GABPα expression showed substantially reduced IL-7Rα expression on thymocytes but normal expression on B220+ fetal liver B cells, demonstrating lineage-specific transcriptional regulation.\",\n      \"method\": \"ChIP, electrophoretic mobility shift assay, GABPα hypomorphic mouse model, flow cytometry\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal ChIP and in vivo genetic model with specific phenotypic readout\",\n      \"pmids\": [\"15361867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GABP binds the YAP (Yes-associated protein) promoter and activates YAP transcription; GABP depletion downregulates YAP causing G1/S cell-cycle block and increased cell death rescued by YAP reconstitution. GABP transcriptional activity is inhibited by oxidative stress (acetaminophen-induced glutathione depletion), and Hippo signaling inhibits GABP activity through multiple mechanisms. In human liver cancers, elevated nuclear GABP correlates with enhanced YAP expression.\",\n      \"method\": \"ChIP, siRNA knockdown, cell cycle analysis, rescue experiments with YAP overexpression, acetaminophen liver injury model, IHC\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus epistasis rescue experiments, in vivo model, multiple orthogonal methods\",\n      \"pmids\": [\"23684612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"METTL23 (a methyltransferase-like protein) physically interacts with GABPα in both nucleus and cytoplasm; overexpression of METTL23 increases transcriptional activity at the THPO promoter, while siRNA knockdown of METTL23 decreases expression of ATP5B (a known GABP target gene), establishing METTL23 as a transcriptional partner that modulates GABP activity.\",\n      \"method\": \"Co-immunoprecipitation, overexpression, siRNA knockdown, luciferase promoter assay, subcellular localization\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — Co-IP with functional transcription assay, single lab study\",\n      \"pmids\": [\"24501276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GABP (as a multimeric complex) is the sole ETS transcription factor that selectively binds the mutant TERT promoter (harboring -124C>T or -146C>T mutations creating a de novo ETS motif) in glioblastoma and other cancer types; allelic GABP recruitment is observed across four cancer types and tandem flanking native ETS motifs cooperate with the mutation to activate TERT, likely by facilitating GABP heterotetramer binding.\",\n      \"method\": \"ChIP-seq, EMSA, luciferase reporter assay, allele-specific binding analysis across multiple cancer cell lines\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — multiple orthogonal methods, replicated across four cancer types, mechanistically defined\",\n      \"pmids\": [\"25977370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CAPER coactivates the nuclear receptor ERR-α to drive GABPA transcription in response to glucose/nutrient signaling, thereby linking nutrient-induced mitochondrial energy metabolism to GABP-dependent transcriptional programs; inhibition of CAPER arrests nutrient-dependent ATP generation and suppresses GABPA expression.\",\n      \"method\": \"siRNA knockdown, gene expression analysis, metabolic assays (ATP measurement, oxygen consumption), ChIP\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — multiple functional assays but indirect evidence for GABPA as downstream target of ERR-α/CAPER\",\n      \"pmids\": [\"25830341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GABPA recruitment to mutant TERT promoters mediates long-range chromatin interactions and enrichment of active histone marks (H3K4me3, H3K27ac) to drive TERT transcription; CRISPR-mediated reversion of mutant TERT promoters abrogated GABPA binding and long-range interactions, eliminated active histone marks, and suppressed TERT transcription, while de novo introduction of a TERT promoter mutation enabled GABPA binding and TERT upregulation.\",\n      \"method\": \"Chromatin conformation capture (3C/ChIA-PET), CRISPR/Cas9 editing, ChIP-seq, luciferase reporter assay\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — CRISPR-based gain and loss of function with multiple chromatin-based readouts, mechanistically rigorous\",\n      \"pmids\": [\"27650951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GABPA directly activates DICER1 transcription by binding its promoter; GABPA depletion reduced DICER1 expression and robustly increased cellular invasion in thyroid carcinoma cells independently of TERT promoter mutations. Forced DICER1 expression rescued the invasiveness of GABPA-depleted cells, establishing DICER1 as a downstream effector of GABPA in suppressing invasion/metastasis.\",\n      \"method\": \"siRNA/shRNA knockdown, luciferase promoter assay with GABPA-binding site mutation, rescue overexpression, invasion assay, patient cohort correlation analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — promoter mutagenesis, epistasis rescue experiment, and in vivo patient data; multiple orthogonal methods\",\n      \"pmids\": [\"30181547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GABPA directly activates transcription of FOXA1 and GATA3, key transcription factors driving luminal differentiation of urothelial cells in bladder cancer; GABPA ablation inhibited TERT expression but increased proliferation, stem/invasive phenotypes, and cisplatin resistance, while overexpression exhibited opposite effects and inhibited in vivo metastasis in a xenograft model, establishing GABPA as a master regulator of luminal identity.\",\n      \"method\": \"ChIP, shRNA/CRISPR knockout, overexpression, xenograft mouse model, invasion/stemness assays, TCGA dataset analysis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP for direct target validation, in vivo xenograft, multiple phenotypic readouts, replicated in patient datasets\",\n      \"pmids\": [\"31802036\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABPA is an ETS-family transcription factor that forms obligate heterodimers/heterotetramers with GABPB subunits (which provide ankyrin-repeat-mediated protein–protein interaction and a conserved transcriptional activation domain) to bind GGA-containing promoter elements and activate target genes including IL-7Rα, YAP, DICER1, FOXA1, GATA3, and ATP5B; uniquely among ETS factors, GABP heterotetramers are selectively recruited to cancer-specific mutant TERT promoters (−124C>T/−146C>T), where they drive long-range chromatin interactions and active histone mark deposition to reactivate TERT transcription, while in normal developmental contexts GABPA functions as a tumor suppressor by maintaining luminal differentiation and suppressing invasion.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABPA is an ETS-family transcription factor that directly binds target gene promoters to activate transcriptional programs controlling cellular differentiation, invasion suppression, and mitochondrial energy metabolism. GABPA maintains luminal identity in urothelial cells by directly activating FoxA1 and GATA3 transcription, thereby suppressing aggressive and metastatic phenotypes [PMID:31802036], and inhibits invasion in papillary thyroid carcinoma by directly activating DICER1 transcription, as demonstrated by promoter mutagenesis and functional rescue [PMID:30181547]. GABPA's transcriptional activity is modulated by the co-regulator METTL23, which physically interacts with GABPA and enhances activity at target promoters including THPO and ATP5B [PMID:24501276], and its own expression is regulated upstream by the CAPER–ERRα axis in response to glucose signaling, coupling nutrient availability to mitochondrial ATP generation [PMID:25830341].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing that GABPA's transcriptional output is modulated by a physical co-regulator: METTL23 was shown to interact with GABPA and enhance its activity at target promoters (THPO, ATP5B), revealing that GABPA does not act alone but requires co-regulatory partners for full transcriptional function.\",\n      \"evidence\": \"Co-immunoprecipitation, overexpression and siRNA knockdown with promoter activity and target gene expression readouts in human cells\",\n      \"pmids\": [\"24501276\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Only a single study with Co-IP; independent confirmation of the METTL23–GABPA interaction by orthogonal methods is lacking\",\n        \"Whether METTL23 modifies GABPA (e.g. via its putative methyltransferase activity) or acts as a scaffolding co-regulator is unresolved\",\n        \"The full set of promoters at which METTL23 influences GABPA activity is unknown\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealing how GABPA expression is itself regulated: CAPER coactivates ERRα to drive GABPA transcription in response to glucose, linking upstream nutrient signals to GABPA-dependent mitochondrial energy metabolism and cell proliferation.\",\n      \"evidence\": \"CAPER inhibition/knockdown with ATP generation, cell proliferation, and GABPA transcriptional output measurements; coactivation assays with ERRα\",\n      \"pmids\": [\"25830341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single study; the CAPER–ERRα–GABPA axis has not been confirmed across multiple cell types\",\n        \"Whether GABPA is the sole ERRα target mediating the metabolic phenotype or one of several effectors is unclear\",\n        \"Direct ERRα binding to the GABPA promoter was not demonstrated by chromatin immunoprecipitation\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defining a direct transcriptional target through which GABPA suppresses invasion: GABPA was shown to directly activate DICER1 transcription, with binding-site mutagenesis abolishing promoter activity and forced DICER1 re-expression rescuing invasiveness caused by GABPA loss, establishing a GABPA→DICER1 anti-invasion axis in thyroid carcinoma.\",\n      \"evidence\": \"siRNA knockdown, promoter reporter assays with binding-site mutagenesis, DICER1 rescue experiments, patient tissue correlations in papillary thyroid carcinoma\",\n      \"pmids\": [\"30181547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the GABPA–DICER1 axis operates in tissues beyond papillary thyroid carcinoma is untested\",\n        \"The downstream miRNA targets of DICER1 that mediate invasion suppression are not identified\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Establishing GABPA as a master regulator of luminal differentiation: GABPA directly activates FoxA1 and GATA3 to maintain luminal identity in urothelial cells, and its loss triggers invasion, stemness, and cisplatin resistance, demonstrating a differentiation-gating function with metastatic consequences.\",\n      \"evidence\": \"GABPA depletion/overexpression with proliferation, invasion, stemness and drug-resistance readouts; in vivo xenograft metastasis model; TCGA/GEO dataset correlations in bladder cancer\",\n      \"pmids\": [\"31802036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether GABPA directly binds FoxA1 and GATA3 promoters was not confirmed by chromatin immunoprecipitation\",\n        \"How GABPA activity is regulated in the context of urothelial differentiation is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The genome-wide target repertoire of GABPA and how its activity is selectively directed to different promoter subsets (differentiation vs. metabolic vs. invasion) in different tissue contexts remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genome-wide ChIP-seq study defining context-dependent GABPA occupancy has been reported in this timeline\",\n        \"Structural basis of GABPA–GABPB1 heterodimerization and how co-regulators like METTL23 modulate DNA-binding specificity is unresolved\",\n        \"Whether GABPA loss-of-function mutations are causative for human disease has not been established by direct genetic evidence\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"METTL23\",\n      \"GABPB1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GABPA is an ETS-family transcription factor that heterodimerizes with GABPB subunits through its ETS domain and a C-terminal extension to form obligate heterodimers and heterotetramers that bind GGA-containing promoter elements and activate transcription of diverse target genes including IL-7Rα, YAP, DICER1, FOXA1, and GATA3 [PMID:8441384, PMID:9461436, PMID:15361867, PMID:30181547, PMID:31802036]. The GABPB subunits contribute ankyrin-repeat-mediated protein–protein interaction surfaces and a conserved glutamine-rich transcriptional activation domain, while GABPA provides all DNA-contact specificity [PMID:8441384, PMID:7799916, PMID:9461436]. Uniquely among ETS factors, GABP heterotetramers are selectively recruited to cancer-associated mutant TERT promoters (−124C>T/−146C>T), where they establish long-range chromatin interactions and active histone marks to reactivate TERT transcription [PMID:25977370, PMID:27650951]. In normal epithelial and immune contexts, GABPA functions as a lineage-specific transcriptional regulator—driving T-cell IL-7Rα expression, luminal differentiation in urothelium via FOXA1/GATA3, and suppression of invasion through DICER1 activation [PMID:15361867, PMID:31802036, PMID:30181547].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing that GABP is a heteromeric transcription factor resolved how the DNA-binding (ETS domain in GABPA) and transcriptional activation functions are partitioned between distinct subunits.\",\n      \"evidence\": \"cDNA cloning of E4TF1 subunits, recombinant expression in E. coli, and gel retardation assays\",\n      \"pmids\": [\"8441384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural detail of the heterodimer interface\", \"Activation domain not yet mapped\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of NRF-2 as identical to GABP and mapping of a conserved ~70 amino acid activation domain in all four beta/gamma subunits established the molecular basis for GABP-dependent transcriptional activation.\",\n      \"evidence\": \"GAL4-fusion transcription assays and DNA-binding reconstitution with recombinant subunits\",\n      \"pmids\": [\"7799916\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how beta subunits enhance DNA-binding affinity at tandem sites unknown\", \"In vivo target gene repertoire undefined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"The crystal structure of the GABPA/GABPB ETS–ankyrin repeat complex on DNA defined the atomic-level protein–protein and protein–DNA interfaces, explaining how GABPB is recruited exclusively through GABPA contacts.\",\n      \"evidence\": \"X-ray crystallography at 2.15 Å resolution of the ternary complex\",\n      \"pmids\": [\"9461436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heterotetramer assembly on tandem sites not structurally resolved\", \"No structural insight into full-length subunits or activation domain\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that GABPA is essential for IL-7Rα expression specifically in T cells but dispensable in B cells revealed lineage-specific transcriptional regulation by GABP in immune development.\",\n      \"evidence\": \"ChIP, EMSA, and GABPA hypomorphic mouse model with flow cytometric phenotyping\",\n      \"pmids\": [\"15361867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of T-cell versus B-cell specificity beyond PU.1 compensation unclear\", \"Downstream consequences for thymocyte development not fully delineated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that GABP directly activates YAP transcription and that oxidative stress inhibits GABP activity connected GABP to Hippo pathway signaling and cell cycle control.\",\n      \"evidence\": \"ChIP, siRNA knockdown with YAP rescue, acetaminophen liver injury model, immunohistochemistry in human liver cancers\",\n      \"pmids\": [\"23684612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of oxidative stress-mediated GABP inhibition not defined at the molecular level\", \"Whether GABP–YAP axis operates outside hepatocytes unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of GABP as the sole ETS factor selectively recruited to mutant TERT promoters across multiple cancer types answered how recurrent TERT promoter mutations reactivate telomerase, revealing that de novo ETS motifs and flanking native ETS sites cooperate to recruit GABP heterotetramers.\",\n      \"evidence\": \"ChIP-seq, EMSA, luciferase reporters, allele-specific binding across four cancer cell lines\",\n      \"pmids\": [\"25977370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for heterotetramer selectivity at mutant versus wild-type TERT promoter unclear\", \"Whether other cofactors contribute to allele-specific recruitment not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"CRISPR-based gain- and loss-of-function experiments demonstrated that GABPA binding at mutant TERT promoters is both necessary and sufficient to establish long-range chromatin interactions and active histone marks, providing a complete chromatin-level mechanism for mutation-driven TERT reactivation.\",\n      \"evidence\": \"CRISPR/Cas9 editing of TERT promoter mutations, 3C/ChIA-PET, ChIP-seq for H3K4me3 and H3K27ac\",\n      \"pmids\": [\"27650951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of distal regulatory elements contacted by GABP-mediated loops not fully characterized\", \"Whether pharmacological disruption of GABP–TERT interaction is feasible not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of DICER1 as a direct GABPA target whose loss mediates the pro-invasive phenotype of GABPA depletion established GABPA as a suppressor of invasion through miRNA biogenesis, independent of its role in TERT regulation.\",\n      \"evidence\": \"Promoter mutagenesis, siRNA/shRNA knockdown, DICER1 rescue of invasion phenotype in thyroid carcinoma cells\",\n      \"pmids\": [\"30181547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific miRNAs downstream of DICER1 mediating invasion suppression not identified\", \"Whether this axis operates in non-thyroid tissues not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that GABPA directly activates FOXA1 and GATA3 to drive luminal differentiation in urothelial cells established GABPA as a master regulator of epithelial cell identity, explaining the paradox that GABPA loss can promote proliferation and invasion even while reducing TERT expression.\",\n      \"evidence\": \"ChIP, CRISPR knockout, xenograft metastasis model, TCGA dataset analysis\",\n      \"pmids\": [\"31802036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling GABPA expression in urothelium not defined\", \"Whether GABPA drives luminal programs in other epithelial tissues not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the structural basis for GABP heterotetramer selectivity at mutant versus wild-type TERT promoters, the complete downstream target repertoire in different lineages, and whether GABPA can be therapeutically targeted to selectively suppress mutant-TERT-driven cancers without disrupting its tumor-suppressive differentiation programs.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No heterotetramer structure on tandem ETS sites available\", \"No systematic comparison of GABPA target genes across tissue types\", \"No therapeutic strategy addressing the dual oncogene-tumor suppressor paradox\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 4, 6, 8, 9, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 5, 6, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 3, 4, 6, 8, 9, 10]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [\n      \"GABP heterodimer (GABPA/GABPB)\",\n      \"GABP heterotetramer\"\n    ],\n    \"partners\": [\n      \"GABPB1\",\n      \"GABPB2\",\n      \"METTL23\",\n      \"TERT\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}